Glucagon-like peptide 1 (1–37) converts intestinal epithelial cells into insulin-producing cells

AUTOR(ES)

Suzuki, Atsushi

FONTE

The National Academy of Sciences

RESUMO

Glucagon-like peptide (GLP) 1 is produced through posttranslational processing of proglucagon and acts as a regulator of various homeostatic events. Among its analogs, however, the function of GLP-1-(1–37), synthesized in small amounts in the pancreas, has been unclear. Here, we find that GLP-1-(1–37) induces insulin production in developing and, to a lesser extent, adult intestinal epithelial cells in vitro and in vivo, a process mediated by up-regulation of the Notch-related gene ngn3 and its downstream targets, which are involved in pancreatic endocrine differentiation. These cells became responsive to glucose challenge in vitro and reverse insulin-dependent diabetes after implantation into diabetic mice. Our findings suggest that efficient induction of insulin production in intestinal epithelial cells by GLP-1-(1–37) could represent a new therapeutic approach to diabetes mellitus.

Documentos Relacionados

• Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
• Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages
• Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
• Glucagon-like peptide-1 is a physiological incretin in rat.
• Specific Biologic Effects of Intestinal Glucagon-Like Materials